24–25 February 2026 | Murcia, Spain
On 24–25 February 2026, the HealthChain I3 consortium met in Murcia for the project’s Final Event. Hosted by Ticbiomed, the two-day meeting brought together partners, SMEs, healthcare representatives and ecosystem actors to reflect on results, share lessons, and prepare for closure.
Day 1 – Results, Stories & I3 Impact
The first day was open to a broader audience and focused on outcomes and impact.
Over the course of HealthChain, 24 solutions were supported across participating regions. They addressed concrete healthcare challenges — from AI-supported cardiology and chronic pain management to telemedicine for remote areas and mental health risk assessment.
Seven stories illustrated this journey from different perspectives: SMEs, a healthcare organisation, and an ecosystem supporter. What stood out was not only technological progress, but organisational learning. Several speakers underlined that implementation in real healthcare settings often required adaptation, persistence, and close cooperation with clinical teams.
Two panel discussions deepened the reflection.
The first explored interregional collaboration in practice: what it enables, where friction occurs, and what others can realistically replicate. The discussion was straightforward, cooperation across regions creates momentum, but it also demands alignment of expectations, timelines, and procurement realities.
The second panel focused on bridging innovation, investment and deployment. Companies, healthcare buyers and business supporters shared their experiences of bringing solutions closer to market. The I3 Instrument was repeatedly described as a useful bridge, not replacing other funding tools, but filling a gap between validation and scaling.
The afternoon concluded with a forward-looking exchange involving regional and European representatives, connecting project results with broader cohesion and innovation policy objectives.
Day 2 – Operational & Project Closure (Consortium Only)
The second day was reserved for consortium partners and concentrated on practical next steps.
Sessions covered:
- The timeline towards formal project closure
- Final technical and impact reporting
- KPIs and mandatory deliverables
- Financial reporting requirements, eligible costs and audit readiness
- Communication obligations and final dissemination actions
While less visible than the innovation showcases, this phase is essential. Clear reporting, sound financial management and coordinated communication ensure that the results achieved stand on solid ground.
Beyond the Project
Murcia marked the formal end of HealthChain’s implementation phase. At the same time, many conversations focused on continuity — future collaborations, sustaining regional capacity, and keeping the connections alive.
HealthChain was never just about individual pilots. It was about strengthening ecosystems and creating interregional value that outlasts the project timeline.
With the final reporting phase now underway, the consortium moves forward with a shared sense of responsibility and a network that remains active beyond the funding period.
